Feijoa powder supplementation did not improve weight or glucose but lowered systolic blood pressure in adults with prediabetes.
This randomized controlled trial investigated the effects of whole fruit feijoa powder supplementation in adults with overweight and prediabetes. A total of 97 participants were enrolled, with 48 assigned to the feijoa powder group and 49 to the placebo group. All participants followed a low-energy diet for 6 months. The primary outcomes assessed were fasting plasma glucose and body weight, while secondary outcomes included systolic and diastolic blood pressure.
Regarding body weight and glucose, both groups demonstrated a significant decrease during the initial 2-month low-energy diet period, with a gradual upward trajectory observed over the subsequent 4 months. There was no significant difference in body weight or fasting plasma glucose between the feijoa powder and placebo groups over the 6-month follow-up period (treatment-by-time interaction P=0.74 for weight; P=0.09 for glucose).
In contrast, systolic blood pressure declined significantly over 6 months between treatments. Systolic blood pressure in the feijoa group was lower than in the placebo group at months 4 and 6 (treatment-by-time interaction P=0.01). Diastolic blood pressure did not decline significantly between the two treatment groups. No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported in the study.
The study had limitations, including the use of imputation for missing not-at-random data points. Given the lack of reported safety data and the observational nature of the blood pressure findings within a controlled setting, the results should be interpreted with caution. Feijoa powder supplementation may enhance blood pressure improvement achieved through weight loss in adults with overweight and prediabetes, but further research is needed to confirm safety and efficacy.